Quantcast
Last updated on April 17, 2014 at 13:47 EDT

Latest Meningococcal vaccine Stories

2012-12-18 05:02:54

This study is a Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a new Meningococcal Vaccine When Given in Healthy Subjects Age 11 to 26. (PRWEB) December 17, 2012 **Avail Clinical Research is now enrolling for a Meningitis Vaccine Clinical Trial near Orlando Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. Neisseria meningitidis is a leading cause of bacterial meningitis in...

2012-11-08 12:26:57

SWIFTWATER, Pa., Nov. 8, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the Pediatric Infectious Disease Journal (PIDJ) has published the pivotal clinical trial data used by the U.S. Food and Drug Administration (FDA) to support the license expansion for Sanofi Pasteur's meningococcal conjugate vaccine, Menactra(®) (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to...

2012-08-27 06:24:21

MINNEAPOLIS, Aug. 27, 2012 /PRNewswire/ -- The School Nurse Organization of Minnesota (SNOM) has joined 40 state and national health organizations across the country in support of the Voices of Meningitis "Boost Our Rates!" initiative, to help educate parents about the importance of meningococcal vaccination for their preteens and teens. With more than 40 percent of Minnesota teens currently unvaccinated against meningococcal infection, which can cause meningitis, SNOM is bringing "Boost Our...

2012-08-23 06:25:40

DALLAS, Aug. 23, 2012 /PRNewswire/ -- Texas School Nurses Organization (TSNO) has joined more than 30 state and national health organizations across the country in support of the Voices of Meningitis "Boost Our Rates!" initiative, to help educate parents about the importance of meningococcal vaccination for their preteens and teens. With more than a third of Texas teens currently unvaccinated against meningococcal infection, which can cause meningitis, TSNO...

2012-08-22 02:24:24

CHARLESTON, W.V., Aug. 22, 2012 /PRNewswire/ -- The West Virginia Association of School Nurses (WVASN) has joined more than 30 state and national health organizations across the country in support of the Voices of Meningitis "Boost Our Rates!" initiative, to help educate parents about the importance of meningococcal vaccination for their preteens and teens. Since January 2012, 839 adolescents have been vaccinated against meningococcal infection at the Kanawha-Charleston Health Department....

2012-07-31 06:25:14

"Facing Meningitis" video features meningitis survivor, Jamie Schanbaum, and parents of Nicolis Williams HOUSTON, July 31, 2012 /PRNewswire-USNewswire/ -- "If you don't get the vaccine for meningitis, you're literally putting yourself at risk to die," explains meningitis survivor Jamie Schanbaum in the Texas Children's Hospital video, "Facing Meningitis." Schanbaum, a University of Texas student who had both of her legs amputated after contracting meningitis as a college sophomore in...

2012-06-19 02:28:27

CHARLESTON, W.Va., June 19, 2012 /PRNewswire/ -- Parents in West Virginia may be unaware that their adolescent children are at risk of contracting a serious, potentially fatal bacterial infection called meningococcal disease if they have not received the second (booster) dose of meningococcal vaccine now recommended by public health officials. The West Virginia Association of School Nurses (WVASN) has joined organizations and community leaders across the country on a national initiative to...

2012-06-14 18:20:29

PHILADELPHIA, June 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix® [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine]. MenHibrix is a vaccine indicated to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. MenHibrix is approved for use in children aged six weeks through 18...

2012-06-14 06:24:10

ST. LOUIS, June 14, 2012 /PRNewswire/ -- Parents in Missouri may be unaware that their adolescent children are at risk of contracting a serious, potentially fatal bacterial infection called meningococcal disease if they have not received the second (booster) dose of meningococcal vaccine now recommended by public health officials. The Missouri Association of School Nurses (MASN) has joined organizations and community leaders across the country on a national initiative to ensure that parents...

2012-06-11 02:26:04

ATLANTA, June 11, 2012 /PRNewswire/ -- Parents in Georgia may be unaware that their adolescent children are at risk of contracting a serious, potentially fatal bacterial infection called meningococcal disease if they have not received the second (booster) dose of meningococcal vaccine now recommended by the Centers for Disease Control and Prevention (CDC), the CDC's Advisory Committee on Immunization Practices and the American Academy of Pediatrics. The Georgia Association of School Nurses...